entertainment -WSS

entertainment

author：leisure time 2025-09-30 16:25:11 - browse：1

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of expert advisers to the Food and Drug Administration on Friday voted in favor of expanding the use of CAR-T therapy in blood cancer, despite concerns about the powerful treatment’s side effects.

The group voted 11-0 that the benefits of Carvykti, a CAR-T medicine from Johnson & Johnson and Legend Biotech, outweighed its risk for patients with multiple myeloma whose disease has persisted despite initial treatment. The same panel voted 8-3 in favor of Abecma, from Bristol Myers Squibb and 2seventy Bio, for multiple myeloma patients who’ve received at least two lines of therapy. Currently both medicines are approved only for patients who have been treated for myeloma with four or more medications.

In clinical trials, each drug proved to significantly delay disease progression compared to standard therapy. But zooming in on the data, the FDA observed an alarming imbalance of deaths in the early months of both studies, finding that more patients in the CAR-T group died of myeloma or side effects than those receiving the standard of care.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

WSS

In Spain, a hospital brews its own CAR

FDA advisers back CAR

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

Why health records don't always know when patients are dead

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Christmas in the PICU brings some surprising joy

Wikipedia

entertainment

entertainment

At least 13 dead in Texas as scorching temps continue

President Biden's budget: Here's what you might have missed

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

EPA limits use of carcinogenic gas for sterilizing medical devices

Guidelines to prevent youth baseball injuries need more muscle

Christmas in the PICU brings some surprising joy

Virginia high school admissions case could be legal follow

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

What does generative AI mean for health care? We asked experts

Violet CEO on training clinicians to promote more inclusive care

explore

Editas, Vertex strike deal on CRISPR

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

In Spain, a hospital brews its own CAR

UCLA team creates talking throat patch for voice disorders

Readout Newsletter: The latest on Moderna, Apellis, and Merck

As AI in medicine takes off, can 'human in the loop' prevent harm?

focus

focus

leisure time

entertainment